Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1571207.
Leukemia & Lymphoma
Volume 60, 2019 - Issue 7
Commentary
Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’
Prithviraj BoseDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
http://orcid.org/0000-0002-4343-5712
http://orcid.org/0000-0002-4343-5712, & Varsha GandhiDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USA; ;Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
http://orcid.org/0000-0002-3172-9166
http://orcid.org/0000-0002-3172-9166![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})